Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review

Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review

Background: Prostate-specific membrane antigen (PSMA) is not sufficiently overexpressed in a small proportion of prostate cancer (PCa) patients, who require other strategies for imaging and/or treatment. We reviewed potential targets other than PSMA for PCa theranostics in nuclear medicine that have...

Full description

Bibliographic Details
Main Authors: Mathieu Gauthé, Paul Sargos, Eric Barret, Gaëlle Fromont-Hankard, Jean-Baptiste Beauval, Laurent Brureau, Gilles Créhange, Raphaële Renard-Penna, Charles Dariane, Gaëlle Fiard, Romain Mathieu, Guilhem Roubaud, Alain Ruffion, Morgan Rouprêt, Guillaume Ploussard, on behalf of the CC-AFU
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
nuclear medicine
therapeutics
molecular imaging
Online Access:https://www.mdpi.com/2077-0383/10/21/4909

Similar Items

Similar Items